首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1439650

美容植入物 - 全球市場考量、競爭狀況、市場預測 (2030)

Aesthetic Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2024年至2030年的預測期內，全球美容植入物市場規模預計將以7.82%的複合年增長率成長。由於乳癌盛行率增加、整容和重建手術數量增加、與美容植入物相關的產品不斷推出以及對有吸引力的身體外觀的需求不斷增加等多種因素，該市場正在出現積極增長。因此，預計在 2024 年至 2030 年的預測期內，市場將以顯著的複合年增長率成長。

美容植入物市場動態

美容植入物市場的主要驅動因素之一是全世界乳癌盛行率的不斷上升。例如，根據世界衛生組織（WHO）2023年發佈的數據，2020年全球有230萬名女性被診斷出罹患乳癌。根據相同的來源和統計數據，在過去五年中，全世界有 780 萬名女性被診斷出罹患乳癌。因此，隨著乳癌在全球範圍內的盛行率不斷上升，對乳房植入物的需求也可能會激增，從而在預測期內（2024-2030年）推動整個美容植入物市場的發展。

此外，美容植入物市場的另一個主要成長因素是美容和重建手術的增加。例如，根據《2020年整形外科統計報告》，在美國進行的1,560萬例整形手術中，230萬例為整容手術，1,320萬例為微創手術。根據上述數據，2020年重建手術數量為680萬例（較2019年增加3%）。此外，根據上述數據，2020年乳房假體數量為193,073件，其中矽膠假體佔總數的84%，鹽水假體佔16%。因此，整容和重建手術的興起將增加對整容植入物的需求，從而推動整個整容植入物市場的成長。

因此，在 2024 年至 2030 年的預測期內，上述因素將共同推動美容植入物市場的發展。

然而，與美容植入物相關的感染和美容植入物的高成本可能會阻礙全球美容植入物市場的成長。

COVID-19 大流行對美容植入物市場產生了負面影響，不僅因為住院人數有限，還因為與患有 COVID-19 的患者相比，擇期手術沒有得到優先考慮。封鎖規定、人員短缺以及口罩和個人防護裝備的短缺對尋求手術的患者的入院產生了重大影響。然而，隨著大規模疫苗接種、放鬆封鎖規定、恢復擇期手術、口罩、個人防護裝備和工作人員的供應，所有這些措施都重回正軌，美容植入市場再次獲得動力，預計未來將進一步增長。預測期2024-2030 年。

北美預計將主導整個美容植入物市場。

在所有地區中，北美預計將在 2023 年主導全球美容植入物市場，並且在 2024-2030 年預測期內也將佔主導地位。乳癌盛行率的增加和美容植入物相關產品的增加等因素預計將增加北美市場對美容植入物的需求。

根據美國癌症協會2023年發佈的最新數據，到2022年底，美國45歲以下的女性中，八分之一的女性將患有浸潤性乳癌；2例確診病例為45歲以上的女性。55 歲。因此，隨著乳癌盛行率的不斷增加，對乳房植入物的需求也可能會激增，這可能會在預測期內（2024-2030年）推動整個美容植入物市場的發展。

此外，其他因素，例如越來越多地推出與美容植入物相關的產品，也可能推動該地區整體美容植入物市場的發展。例如，2022年2月，全球最大的純美容醫學公司Merz Aesthetics在美國啟動了深層組織增強項目，旨在改善21歲及以上成年人中度至重度下顎線缺失的情況。RadiesseR(+) 利多卡因注射植入物用於注射（皮下和/或骨膜上）。

因此，上述因素的相互作用可能會為北美地區美容植入物市場的成長創造有利的環境。

本報告研究和分析了全球美容植入物市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

美容植入物市場驅動因素
- 乳癌發生率不斷上升
- 整容和重建手術增加
- 與美容植入物相關的產品發佈和批准數量增加
- 對有吸引力的外表的需求不斷增加
美容植入物市場的限制與挑戰
- 與美容植入物相關的感染
- 美容植入物的成本高昂
美容植入物市場機遇
- 3D列印技術在乳房再造的應用
- 增加美容植入物的研發活動
- 提高對美容植入物的認識

第5章波特美容植體市場的五力分析

第6章COVID-19對美容植體市場的影響分析

第7章美容植入物市場佈局

依產品類型
- 乳房植入物
- 身體輪廓植入物
- 客製化植入物
- 鼻子植入物
- 植牙
- 其他
性別
- 男性
- 女性
按最終用戶
- 醫院
- 美容診所
- 門診手術中心
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章美容植體市場：全球公司佔有率分析 - 3 至 5 家主要公司

第9章美容植入物市場的公司與產品概況

POLYTECH Health & Aesthetics GmbH
Sientra Inc
Surgiform Innovative Surgical Products
GC Aesthetics
Dentsply Sirona
Institut Straumann AG
AVINENT
AbbVie
Establishment Labs S.A.
Mentor (Johnson & Johnson Medical Ltd)
3M
Zimmer Biomet
Alpha Aesthetics
Symatese
Integra LifeSciences
Sebbin
IDEAL IMPLANT INCORPORATED
Lattice Medical
Guangzhou Wanhe Plastic Material Co Ltd
CEREPLAS

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0487

Aesthetic Implants Market By Product Type (Breast Implants, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, And Others), By Gender (Male And Female), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of breast cancer and increase in number of cosmetic & reconstructive plastic surgeries

The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030. The aesthetic implants market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance. Therefore, the market for aesthetic implants is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Aesthetic Implants Market Dynamics:

One of the main drivers of the aesthetic implant market is the increasing prevalence of breast cancer globally. For instance, as per the World Health Organization (WHO) published data in the year 2023, in 2020, 2.3 million women were diagnosed with breast cancer throughout the world. According to the same source and statistics, across the world, 7.8 million women would have been diagnosed with breast cancer in the previous five years. Therefore, with the increasing global prevalence of breast cancer, the need for breast implants could also surge, driving the overall aesthetic implants market forward over the forecast period (2024-2030).

Moreover, another key factor that is responsible for the growth of the aesthetic implants market is the increase in the number of cosmetic & reconstructive surgeries. For instance, as per the plastic surgery statistics report in the year 2020, in America, out of 15.6 million cosmetic procedures, 2.3 million were cosmetic surgical procedures whereas 13.2 million procedures were minimally-invasive. According to the source mentioned above, in 2020, reconstructive procedures were 6.8 Million (a 3% increase from 2019). Additionally, as per the above-referenced source, in 2020, there were 193,073 breast augmentations, silicone implants accounting for 84% of all procedures, and saline implants accounting for 16%. Thus, an increase in the number of cosmetic & reconstructive surgeries will increase the demand for aesthetic implants, thereby propelling the growth of aesthetic implants' overall market.

Therefore, the factors stated above collectively will drive the aesthetic implants market during the forecast period from 2024-2030.

However, infections associated with the aesthetic implants and the high cost of aesthetic implants can hamper the global aesthetic implant market growth

The Coronavirus pandemic (COVID-19) has negatively impacted the market for aesthetic implants as hospital admissions were limited, as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks and PPE kits made a huge impact on patient admissions in hospitals for surgeries. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, with all these measures back on track the aesthetic implants market has picked momentum again and is expected to further grow during the forecast period from 2024-2030.

Aesthetic Implants Market Segment Analysis:

Aesthetic Implants Market by Product Type (Breast Implant, Body Contouring Implants, Custom-Made Implants, Nasal Implants, Dental Implants, and Others), Gender (Male and Female), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In by product type segment of the dental implants market, is expected to share a significant revenue share in the year 2023. Benefits associated with dental implants are, as they are used to prevent bone loss, they act like natural teeth, the implants last a lifetime, they can be required to keep adjacent teeth stable, improve the appearance, oral health, self-esteem as well as speech, they are durable, help to get free from gum disease, help to prevent facial sagging & premature aging. Thus, these benefits associated with dental implants can increase the demand for aesthetic implants, which could drive the aesthetic implants' overall market growth.

However, various technologically advanced aesthetic implants receive approvals, this can also be expected to drive the overall market growth for aesthetic implants. For instance, in June 2022, Biotech Dental SAS, a designer and manufacturer of medical devices and digital solutions for dental surgeons, orthodontists, and dental prosthesis laboratories, received United States (US) Food and Drug Administration (FDA) approval for Kontact Dental Implant System, the implant system is designed to support single-unit, multiple-unit, or overdenture dental restorations in partly or completely edentulous patients.

Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for aesthetic implants, which in turn would provide a conducive growth environment for the overall aesthetic implants market during the forecast period from 2024-2030.

North America is expected to dominate the overall Aesthetic Implants Market:

Among all the regions, North America is expected to dominate the global aesthetic implants market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants are expected to increase the demand of aesthetic implants in the North America market.

According to the latest data published by the American Cancer Society in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older. Thus, with the increasing prevalence of breast cancer, the need for breast implants could also surge, this can drive the overall aesthetic implants market forward over the forecast period (2024-2030).

Furthermore, another factor such as the rise in the product launches related to aesthetic implants could drive the aesthetic implant's overall market in the region. For instance, in February 2022, Merz Aesthetics, the world's largest dedicated medical aesthetics company, announced the commercial launch of Radiesse® (+) Lidocaine injectable implant, for deep injection (subdermal and/or supraperiosteal) in the United States for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.

Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the aesthetic implants market.

Aesthetic Implants Market Key Players:

Some of the key market players operating in the aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.

Recent Developmental Activities in the Aesthetic Implants:

In May 2022, GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing healthcare aesthetic solutions, announced the launch of an Innovative Nipple Areola Complex (NAC) Reconstruction Implant: FixNip(TM) NRI

In May 2022, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced the launch of its next generation of breast implants, PERLE(TM). It's a cutting-edge series of smooth breast implants with a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel), and an upgraded version of GCA's long-term great safety record

In November 2019, BellaSeno, a German additive manufacturing start-up & Evonik, a chemical company, BellaSeno, and Evonik have formed a long-term partnership to develop a new breast implant technology based on Evonik's RESOMER bioresorbable polymer. RESOMER will be used in BellaSeno's 3D-printed senella breast scaffold. The product is designed to be used after reconstruction, augmentation, or revision surgery. It is resorbed by the body and gradually replaced by natural breast tissue

Key Takeaways from the Aesthetic Implants Market Report Study:

Market size analysis for current aesthetic implants market (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the aesthetic implants market
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
Key companies dominating the global aesthetic implants market
Various opportunities are available for the other competitor in the aesthetic implants market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current aesthetic implants market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for aesthetic implant market growth in the coming future?

Target Audience who can be benefited from this Aesthetic Implants Market Report Study:

Aesthetic implants providers
Research organizations and consulting companies
Aesthetic implants-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in aesthetic implants
Various end-users who want to know more about the aesthetic implants market and the latest technological developments in the aesthetic implants

Frequently Asked Questions for Aesthetic Implants:

1. What are Aesthetic Implants?

Aesthetic implant placement is driven by both a restorative and biological philosophy. The implant is positioned to meet the contour requirements for a good repair and should be positioned biologically to allow for the preservation of both hard and soft tissue architecture.

2. What is the market for Global Aesthetic Implants?

The global aesthetic implants market is estimated to grow at a CAGR of 7.82% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Aesthetic implants market?

The Aesthetic implants market is witnessing positive market growth owing to the factors such as the increasing prevalence of breast cancer, increase in the number of cosmetic & reconstructive surgeries, rise in the product launches related to aesthetic implants, and increasing need for attractive physical appearance

4. Who are the key players operating in the Aesthetic implants market?

Some of the key market players operating in the Aesthetic implants market include POLYTECH Health & Aesthetics GmbH, Sientra, Inc, Surgiform Innovative Surgical Products, GC Aesthetics, Dentsply Sirona, Institut Straumann AG, AVINENT, AbbVie, Establishment Labs S.A., Mentor (Johnson & Johnson Medical Ltd), 3M, Zimmer Biomet, Alpha Aesthetics, Symatese, Integra LifeSciences, Sebbin, IDEAL IMPLANT INCORPORATED, Lattice Medical, CEREPLAS, Guangzhou Wanhe Plastic Material Co Ltd, and among others.

5. Which region has the highest share in the Aesthetic implants Market?

North America is expected to dominate the global aesthetic implants market. Factors contributing to the growth are the increasing prevalence of breast cancer and the rise in product launches related to aesthetic implants, which are contributing to the growth of the aesthetic implants market in the North America region.

1.Aesthetic implants Market Report Introduction

2. Aesthetic implants Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The US
3.2. Europe
3.3. Japan
3.4. China

4. Aesthetic Implants Market Key Factors Analysis

4.1. Aesthetic Implants Market Drivers
- 4.1.1. Increasing Prevalence of Breast Cancer
- 4.1.2. Increase in Number of Cosmetic & Reconstructive Surgeries
- 4.1.3. The rise in the Products Launches & Approvals Related to Aesthetic Implants
- 4.1.4. Increasing Need for Attractive Physical Appearance
4.2. Aesthetic Implants Market Restraints And Challenges
- 4.2.1. Infections Associated With the Aesthetic Implants
- 4.2.2. High Cost of Aesthetic Implants
4.3. Aesthetic Implants Market Opportunities
- 4.3.1. 3D Printing Technology in Breast Reconstruction
- 4.3.2. Increasing Research and Development Activities in Aesthetic Implants
- 4.3.3. Increasing Awareness about Aesthetic Implants

5. Aesthetic Implants Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Aesthetic Implants Market

7. Aesthetic Implants Market Layout

7.1. By Product Type
- 7.1.1. Breast Implant
- 7.1.2. Body Contouring Implants
- 7.1.3. Custom-Made Implants
- 7.1.4. Nasal Implants
- 7.1.5. Dental Implants
- 7.1.6. Others
7.2. By Gender
- 7.2.1. Male
- 7.2.2. Female
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Cosmetology Clinics
- 7.3.3. Ambulatory Surgical Centers
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.1.2. Canada Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.1.3. Mexico Aesthetic Implants Market Size in USD Million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.2. Germany Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.3. United Kingdom Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.4. Italy Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.5. Spain Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.6. Russia Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.2.7. Rest of Europe Aesthetic Implants Market Size in USD Million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.3.2. Japan Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.3.3. India Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.3.4. Australia Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.3.5. South Korea Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.3.6. Rest of Asia Pacific Aesthetic Implants Market Size in USD Million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.4.2. Africa Aesthetic Implants Market Size in USD Million (2021-2030)
  - 7.4.4.3. South America Aesthetic Implants Market Size in USD Million (2021-2030)

8. Aesthetic Implants Market Global Company Share Analysis - Key 3-5 Companies

9. Aesthetic Implants Market Company and Product Profiles

9.1. POLYTECH Health & Aesthetics GmbH
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. Sientra Inc
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. Surgiform Innovative Surgical Products
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. GC Aesthetics
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4. Product Listing
- 9.4.5. Entropy
9.5. Dentsply Sirona
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Institut Straumann AG
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. AVINENT
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. AbbVie
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. Establishment Labs S.A.
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Mentor (Johnson & Johnson Medical Ltd)
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. 3M
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. Zimmer Biomet
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Alpha Aesthetics
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Symatese
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. Integra LifeSciences
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Sebbin
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. IDEAL IMPLANT INCORPORATED
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Lattice Medical
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Guangzhou Wanhe Plastic Material Co Ltd
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. CEREPLAS
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy